WEBULL
News
OSRH
0.5150
+0.98%
0.0050
Weekly Report: what happened at OSRH last week (0202-0206)?
Weekly Report · 1d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 02/02 21:05
OSR Holdings CEO Issues Statement To Shareholders; Says Fundamentals Of Business Remain Strong
Benzinga · 02/02 14:58
OSR Holdings CEO says fundamentals of business ‘remain strong’
TipRanks · 02/02 14:55
OSR Holdings Advances Toward VXM01 Licensing Deal With BCM Europe AG
Reuters · 02/02 14:50
Weekly Report: what happened at OSRH last week (0126-0130)?
Weekly Report · 02/02 10:16
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 01/30 21:05
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 01/29 21:05
OSR Holdings Closes Woori IO Acquisition
Reuters · 01/27 14:52
OSR Holdings Subsidiary Acquires Woori IO to Expand Medtech
TipRanks · 01/27 14:47
OSR HOLDINGS INC: EVALUATING WHETHER A COMBINED PLATFORM COULD SUPPORT A STANDALONE IPO IN KOREA
Reuters · 01/27 14:30
OSR Holdings completes Woori IO acquisition
TipRanks · 01/27 13:50
OSR Holdings Announcecs The Initiation Of A Strategic Review Regarding A Potential Combination Of Its Medical Device Subsidiaries
Benzinga · 01/27 13:37
Weekly Report: what happened at OSRH last week (0119-0123)?
Weekly Report · 01/26 10:16
Woori IO Accelerates Launch of Noninvasive Glucose Wearables Under OSR Holdings
Reuters · 01/22 14:56
Weekly Report: what happened at OSRH last week (0112-0116)?
Weekly Report · 01/19 10:21
Vaximm Appoints Sébastien Wieckowski as Chief Scientific Officer
Reuters · 01/16 14:21
Press Release: Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform
Dow Jones · 01/16 14:20
OSR Holdings Subsidiary Signs Binding VXM01 Licensing Term Sheet
TipRanks · 01/14 14:48
BRIEF-Osr Holdings Inc - Vaximm AG Enters Binding Term Sheet With Bcm Europe AG - SEC Filing
Reuters · 01/14 14:28
More
Webull provides a variety of real-time OSRH stock news. You can receive the latest news about OSR Holdings, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About OSRH
OSR Holdings, Inc. is a global healthcare holding company dedicated to advancing biomedical innovation approaches to health and wellness. Through its subsidiaries, it is engaged in immuno-oncology, regenerative biologics, and medical device technologies. Its operating businesses include developing oral immunotherapies for the treatment of cancer, developing design-augmented (DA) biologics for age-related and other degenerative diseases and neurovascular intervention medical device and systems distribution in Korea. Its subsidiaries include VAXIMM AG (Vaximm); RMC Co., Ltd. (RMC); Darnatein Co., Ltd. (Darnatein), and Woori IO Co., Ltd. (Woori IO). Vaximm is developing oral immunotherapies for the treatment of cancer and immunological disorders. RMC is a Korea-based neurovascular intervention medical device and systems distribution company. Darnatein is developing DA biologics for age-related and other degenerative diseases. Woori IO is a South Korea-based medical device company.